Tff Pharmaceuticals Company Overview
About Tff Pharmaceuticals
TFF Pharmaceuticals (NASDAQ:TFFP), operates in the biopharmaceutical sector focusing on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology. This cutting-edge technology aims to improve the solubility and absorption of poorly water-soluble drugs, a common challenge in drug formulation, thereby enhancing their therapeutic effects. The company is actively engaged in a range of projects across various stages of research and development, aiming to tackle unmet medical needs in areas such as lung disease and fungal infections. The primary objective of Tff Pharmaceuticals is to harness the potential of TFF technology to create a robust pipeline of drug candidates that can offer significant benefits over existing treatments, thus providing improved options for patients and healthcare providers alike.
Snapshot
Operations
Products and/or services of Tff Pharmaceuticals
- Inhalable dry powder formulations targeting severe lung diseases and conditions.
- Technological platform for transforming injectable drugs into inhalable therapies.
- Research collaboration for developing antiviral and antibiotic treatments leveraging dry powder formulations.
- Partnership initiatives for enhancing drug delivery systems in respiratory care.
- Pipeline of therapeutics targeting pulmonary hypertension and chronic obstructive pulmonary disease.
- Advancements in dry powder vaccine delivery technology for infectious diseases.
Tff Pharmaceuticals executive team
- Dr. Harlan F. WeismanPresident, CEO & Director
- Dr. Zamaneh Mikhak M.D.Chief Medical Officer